Preclinical pharmacology of angiotensin II receptor antagonists: update and outstanding issues

American Journal of Hypertension
C I Johnston, J Risvanis

Abstract

The angiotensin II receptor antagonists (AIIRA) represent a new class of antihypertensive agents, with a mechanism of action that differs from that of other classes of antihypertensive agents that also affect the renin-angiotensin system (RAS), such as the angiotensin-converting enzyme (ACE) inhibitors. The AIIRA were developed to overcome several of the deficiencies of ACE inhibitors, which include the following: 1) competitive inhibition of the ACE enzyme results in a reactive increase in renin and angiotensin I (AI) levels, which may overcome the blockade; 2) ACE is a relatively nonspecific enzyme that has substrates in addition to AI, including bradykinin and other tachykinins; thus, inhibition of ACE may also result in accumulation of these substrates; 3) production of AII can occur through non-ACE pathways, in addition to being produced by the primary ACE pathway; these alternative pathways are unaffected by ACE inhibition; and 4) specific adverse effects are associated with inhibition of the ACE enzyme. This review summarizes the preclinical pharmacology of the AIIRA class of agents and describe the means by which the deficiencies associated with ACE inhibition are overcome. The specific characteristics of the new AIIRA ...Continue Reading

Citations

Jun 4, 1999·Journal of Clinical Pharmacology·M M McConnaugheyA J Ingenito
Jun 20, 2002·Journal of Cardiovascular Pharmacology·Maria R Marino, Nimish N Vachharajani
Jan 20, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Eiichi GeshiTakashi Katagiri
Sep 12, 2000·Current Hypertension Reports·M E Fabiani, C I Johnston
Apr 9, 2004·Journal of Cardiovascular Pharmacology·Victor L SerebruanyCharles H Hennekens
Mar 24, 2017·Nutrients·Ceren Daskaya-DikmenBeraat Ozcelik
Jul 7, 2011·Expert Opinion on Pharmacotherapy·Jujhar Bains, William B Smith
Jan 11, 2013·International Journal of Hypertension·Hanna Andersson, Mathias Hallberg
Feb 8, 2005·Cardiology Clinics·Kris Vijayaraghavan, Prakash C Deedwania
Oct 22, 2008·Cardiology Clinics·Usman Javed, Prakash C Deedwania
Jan 25, 2011·Cardiology Clinics·Krishnaswami Vijayaraghavan, Prakash Deedwania

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.